Openbookopenbook
Openbook
ArticlesTagged: oncology

#oncology

Stock analysis posts tagged "oncology" from Openbook.

A sturdy bridge under construction across a deep ravine, with scaffolding in place but the far side still shrouded in morning mist
Market Spotlight

Is Summit Therapeutics a Good Long-Term Investment? SMMT Growth, Profitability and Risks

AstraZeneca's USD 2bn stake removes Summit's financing overhang but buys no licence on ivonescimab. Why the shares gave back most of a 22% pop.

Jack Green·30 Sept 2026
Rows of glass medicine vials moving along a pharmaceutical production line.
Individual Stock Analysis

How Merck (MRK) Makes Its Money: Oncology and Vaccine Fundamentals

A Merck stock analysis of where MRK earns its revenue across oncology, vaccines and animal health, and what the 2028 Keytruda patent expiry changes.

Andrew Menzies·8 Sept 2026
openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.